PTI-3
Identifiers | |
---|---|
IUPAC name
| |
ChemSpider | |
Chemical and physical data | |
Formula | C21H28FN3OS |
Molar mass | 389.53 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
|
PTI-3 is an indole-3-thiazole based synthetic cannabinoid which has been sold as a designer drug. It was first identified in Hungary in 2020,[1] and was made illegal in Italy in June 2021.[2]
See also
References
- ↑ European Monitoring Center for Drugs and Drug Addiction (December 2020). "New psychoactive substances: global markets, glocal threats and the COVID-19 pandemic. An update from the EU Early Warning System" (PDF). Luxembourg: Publications Office of the European Union. doi:10.2810/921262.
{{cite journal}}
: Cite journal requires|journal=
(help) - ↑ "Decreto 1 Giugno 2021. Aggiornamento delle tabelle contenenti l'indicazione delle sostanze stupefacenti e psicotrope, di cui al decreto del Presidente della Repubblica 9 ottobre 1990, n. 309 e successive modificazioni e integrazioni. Inserimento nella tabella I di nuove sostanze psicoattive. (21A03590) (GU Serie Generale n.144 del 18-06-2021)" [Decree of 1 June 2021. Update of the tables containing the indication of narcotic and psychotropic substances, as per the decree of the President of the Republic of 9 October 1990, n. 309 and subsequent amendments and additions. Inclusion in Table I of new psychoactive substances. (21A03590) (GU General Series n.144 of 18-06-2021] (in Italian).
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.